N-terminal Pro-B-type Natriuretic Peptide and Stroke Risk: the Reasons for Geographic and Racial Differences in Stroke Cohort

Overview

Journal Stroke

Specialties Cardiology & Vascular Diseases
Neurology

Date 2014 Apr 24

PMID 24757103

Citations 91

Authors

Mary Cushman

Suzanne E Judd

Virginia J Howard

Brett Kissela

Orlando M Gutierrez

Nancy S Jenny

Ali Ahmed

Evan L Thacker

Neil A Zakai

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Improved identification of those at risk of stroke might improve prevention. We evaluated the association of the cardiac function biomarker N-terminal pro-B-type natriuretic peptide (NT-proBNP) with stroke risk in the 30 239 black and white participants of the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort.

Methods: During 5.4 years of follow-up after enrollment in 2003 to 2007, NT-proBNP was measured in baseline blood samples of 546 subjects with incident ischemic stroke and 956 without stroke.

Results: NT-proBNP was higher with older age and in those with heart disease, kidney disease, atrial fibrillation, and lower low-density lipoprotein-cholesterol. Adjusting for age, race, sex, income, education, and traditional stroke risk factors, there was an increased risk of stroke across quartiles of NT-proBNP; participants with NT-proBNP in the top versus the bottom quartile had a hazard ratio of 2.9 (95% confidence interval, 1.9-4.5). There was no impact of added adjustment for kidney function and heart failure. Among pathogenetic stroke subtypes, the association was largest for cardioembolic stroke, with a hazard ratio of 9.1 (95% confidence interval, 2.9-29.2). Associations did not differ by age, sex, or race, or after excluding those with baseline heart failure or atrial fibrillation. Predicted stroke risk was more accurate in 27% of participants if NT-proBNP was considered after traditional stroke risk factors (P<0.001).

Conclusions: NT-proBNP was a major independent risk marker for stroke. Considering this and other data for stroke, coronary disease, and atrial fibrillation, the clinical use of NT-proBNP measurement in primary prevention settings should be considered.

Citing Articles

Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study.

Fabritz L, Al-Taie C, Borof K, Breithardt G, Camm A, Crijns H Eur Heart J. 2024; 45(47):5002-5019.

PMID: 39215973 PMC: 11646612. DOI: 10.1093/eurheartj/ehae611.

The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet and Metabolites in Chronic Kidney Disease.

Couch C, Ament Z, Patki A, Kijpaisalratana N, Bhave V, Jones A Nutrients. 2024; 16(15).

PMID: 39125339 PMC: 11314466. DOI: 10.3390/nu16152458.

Association between atrial cardiopathy and stroke severity in acute ischemic stroke.

Zhang Y, Lei H, Wu X, Fang S, Lin H, Yuan Q Sci Rep. 2024; 14(1):17049.

PMID: 39048576 PMC: 11269563. DOI: 10.1038/s41598-024-61304-y.

Sex-Associated Metabolites and Incident Stroke, Incident Coronary Heart Disease, Hypertension, and Chronic Kidney Disease in the REGARDS Cohort.

Couch C, Ament Z, Patki A, Kijpaisalratana N, Bhave V, Jones A J Am Heart Assoc. 2024; 13(9):e032643.

PMID: 38686877 PMC: 11179891. DOI: 10.1161/JAHA.123.032643.

Omega-3 Fatty Acids and Risk of Ischemic Stroke in REGARDS.

Ament Z, Patki A, Bhave V, Kijpaisalratana N, Jones A, Couch C Transl Stroke Res. 2024; .

PMID: 38676880 DOI: 10.1007/s12975-024-01256-7.

References

Rutten J, Mattace-Raso F, Steyerberg E, Lindemans J, Hofman A, Wieberdink R . Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study. Hypertension. 2010; 55(3):785-91. DOI: 10.1161/HYPERTENSIONAHA.109.143313. View

Soliman E, Howard G, Meschia J, Cushman M, Muntner P, Pullicino P . Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2011; 42(10):2950-3. PMC: 3185239. DOI: 10.1161/STROKEAHA.111.621367. View

Schneider A, Kissela B, Woo D, Kleindorfer D, Alwell K, Miller R . Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke. 2004; 35(7):1552-6. DOI: 10.1161/01.STR.0000129335.28301.f5. View

Takahashi T, Nakamura M, Onoda T, Ohsawa M, Tanno K, Itai K . Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study. Atherosclerosis. 2009; 207(1):298-303. DOI: 10.1016/j.atherosclerosis.2009.04.029. View

Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engstrom G . Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA. 2009; 302(1):49-57. PMC: 3090639. DOI: 10.1001/jama.2009.943. View

Longstreth Jr W, Kronmal R, Thompson J, Christenson R, Levine S, Gross R . Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke. 2013; 44(3):714-9. PMC: 3583375. DOI: 10.1161/STROKEAHA.112.675942. View

Pullicino P, McClure L, Wadley V, Ahmed A, Howard V, Howard G . Blood pressure and stroke in heart failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Stroke. 2009; 40(12):3706-10. PMC: 2903881. DOI: 10.1161/STROKEAHA.109.561670. View

Hijazi Z, Oldgren J, Andersson U, Connolly S, Ezekowitz M, Hohnloser S . Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation. 2012; 125(13):1605-16. DOI: 10.1161/CIRCULATIONAHA.111.038729. View

Wang T, Larson M, Levy D, Benjamin E, Leip E, Omland T . Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004; 350(7):655-63. DOI: 10.1056/NEJMoa031994. View

10.

Garcia-Berrocoso T, Giralt D, Bustamante A, Etgen T, Jensen J, Sharma J . B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis. Neurology. 2013; 81(23):1976-85. PMC: 3854833. DOI: 10.1212/01.wnl.0000436937.32410.32. View

11.

Howard G, Cushman M, Kissela B, Kleindorfer D, McClure L, Safford M . Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke. 2011; 42(12):3369-75. PMC: 3226886. DOI: 10.1161/STROKEAHA.111.625277. View

12.

Wang T, Gona P, Larson M, Tofler G, Levy D, Newton-Cheh C . Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006; 355(25):2631-9. DOI: 10.1056/NEJMoa055373. View

13.

Choi E, Bahrami H, Wu C, Greenland P, Cushman M, Daniels L . N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail. 2012; 5(6):727-34. PMC: 4124746. DOI: 10.1161/CIRCHEARTFAILURE.112.968701. View

14.

Patton K, Ellinor P, Heckbert S, Christenson R, deFilippi C, Gottdiener J . N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation. 2009; 120(18):1768-74. PMC: 4132053. DOI: 10.1161/CIRCULATIONAHA.109.873265. View

15.

Schnabel R, Larson M, Yamamoto J, Sullivan L, Pencina M, Meigs J . Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010; 121(2):200-7. PMC: 3224826. DOI: 10.1161/CIRCULATIONAHA.109.882241. View

16.

Montaner J, Perea-Gainza M, Delgado P, Ribo M, Chacon P, Rosell A . Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke. 2008; 39(8):2280-7. DOI: 10.1161/STROKEAHA.107.505354. View

17.

Soliman E, Howard G, Prineas R, McClure L, Howard V . Calculating Cornell voltage from nonstandard chest electrode recording site in the Reasons for Geographic And Racial Differences in Stroke study. J Electrocardiol. 2009; 43(3):209-14. PMC: 2856789. DOI: 10.1016/j.jelectrocard.2009.10.002. View

18.

Pencina M, DAgostino Sr R, DAgostino Jr R, Vasan R . Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2007; 27(2):157-72. DOI: 10.1002/sim.2929. View

19.

Morton L, Cahill J, Hartge P . Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol. 2005; 163(3):197-203. DOI: 10.1093/aje/kwj036. View

20.

Silvet H, Young-Xu Y, Walleigh D, Ravid S . Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol. 2003; 92(9):1124-7. DOI: 10.1016/j.amjcard.2003.07.010. View